New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
06:44 EDTPBYIPuma Biotechnology price target raised to $27 from $20 at Leerink
Leerink raised its price target for Puma Biotechnology citing the company's progress in advancing neratinib. The firm keeps an Outperform rating on the stock.
News For PBYI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
10:02 EDTPBYIOn the Fly: Analyst Initiation Summary
Subscribe for More Information
January 22, 2015
16:16 EDTPBYIPuma Biotechnology initiated with an Outperform at RBC Capital
Subscribe for More Information
07:36 EDTPBYIPuma Biotechnology a 'unique takeout candidate,' says Citigroup
Subscribe for More Information
January 21, 2015
19:13 EDTPBYIPuma Biotechnology 1M share Secondary priced at $190.00
Subscribe for More Information
January 20, 2015
16:25 EDTPBYIPuma Biotechnology files to sell 1M shares of common stock
Subscribe for More Information
16:07 EDTPBYIPuma Biotechnology files automatic mixed securities shelf
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use